Market statusData NSENot investment advice
Dr Agarwals Eye Hospital

Dr Agarwals Eye Hospital Latest Share Price (DRAGARWQ)

NSE: DRAGARWQBSE 526783www.dragarwal.com
TechnicalsTV Chart
5,328.50
45.00−0.84%
Overall Score39/100
Day range5,205
₹5,328.50
5,387
52-week4,600
₹5,328.50
6,060
Above low+15.8%
Below high12.1%
Range position50%
Open5,363.50
Prev Close5,373.50
Bid5,328.23100
Ask5,328.77100

TODAY IN ONE LINE

DRAGARWQ slipped 0.8%, lagging Nifty's 0.5% move, supported by recent strong earnings.

With a market cap of ₹2,588.41 Cr., it trades at a P/E of 33.71. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume64957%vs 20D avg
Market Cap₹2,588.41 Cr.
Promoter72.67%
Face Value₹10
Fwd P/E
PEG
EV/EBITDA17.04
P/S4.76
ROA
Beta
Div Payout4.48%
THE STOCK SCORE
Overall Score39/100
Updated 21 Apr

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

Dr Agarwals Eye Hospital flags & news 

Key strengths, potential risks, and recent updates.

5 green flags🚩 0 red flags

Green Flags

  • High Capital EfficiencyROCE of 17.4% indicating pricing power
  • Strong Return on EquityHealthy ROE of 25.2%
  • Healthy Operating MarginsOPM is structurally strong at 30.9%
  • High Promoter HoldingPromoters hold 72.7% skin-in-the-game
  • Zero Pledge RiskNo recent active promoter pledging found

Red Flags

No red flags identified

Latest Dr Agarwals Eye Hospital News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

No recent changes found for this period.
🔒Prime: full history + alerts on this stock
Valuation

Dr Agarwals Eye Hospital Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Dr Agarwals Eye Hospital Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Dr Agarwals Eye Hospital Ltd trades at a P/E of 33.71× and P/B of 7.42×.

Key MetricsMarket + reported · 25 Aug 2026Standalone

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹2,588.41 Cr.
P/E Ratio
33.71
P/B Ratio
7.42
EPS
₹145
Profitability

Profitability

ROE
25.2%
ROCE
17.4%
Net Margin
14.89%
Op Margin
30.9%
Growth

Growth

EPS YoY
Revenue YoY
Qtr Sales
20.2%
Qtr Profit
1.56%
Financial Health

Financial Health

Debt / Equity
0.94
Book Value
₹717
Div Yield
0.13%
Promoter Holding
72.67%
Technicals

Dr Agarwals Eye Hospital Ltd technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Dr Agarwals Eye Hospital Ltd — derived from the latest tape, not yesterday's close.

Dr Agarwals Eye Hospital Ltd last traded at ₹5,328.5 with an intraday range of ₹5,205–₹5,386.5 — latest indicator, pivot and CPR signals below.

Last updated: 25 August 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹5328.50
LevelPrice (₹)Distance% Δ
R45771.33+442.83+8.31%
R35589.83+261.33+4.90%
R25488.17+159.67+3.00%
R15408.33+79.83+1.50%
PIVOT5306.67-21.83-0.41%
CURRENT5328.50
S15226.83-101.67-1.91%
S25125.17-203.33-3.82%
S35045.33-283.17-5.31%
S44863.83-464.67-8.72%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 5295.75P: 5306.67TC: 5317.58
R1
R2
R3
R4
indicator
LTP: 5328.50
PDH: 5400.00
PDL: 5296.00
● Market Sentiment

DRAGARWQ is trading Above CPR, indicating Bullishness

● CPR Width

CPR is Average

● Opening Range

Day's range: 52055386.5

● Price Position

Trading Inside opening range

Financials

Dr Agarwals Eye Hospital Ltd financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for Dr Agarwals Eye Hospital Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.

Dr Agarwals Eye Hospital Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,588.41 Cr. and reported EPS of ₹145.00.

iTap any row for a plain-English meaningChange vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

Dr Agarwals Eye Hospital segment analysis : revenue and profit mix.

Disclosed business segments at Dr Agarwals Eye Hospital with their share of revenue and profit, switchable between consolidated and standalone reporting.

Dr Agarwals Eye Hospital discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for Dr Agarwals Eye Hospital Ltd.

Our AI distills the core fundamental drivers supporting Dr Agarwals Eye Hospital Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

No weaknesses or threats on record.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 44 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.44. Balance sheet risk re-prices growth multiples fast.

  • Return-quality risk. ROE below 20% would indicate weaker capital compounding.

Shareholding

Dr Agarwals Eye Hospital shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Dr Agarwals Eye Hospital — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

AnnualJun 2026

Public23.04%0.04%
Promoters72.67%
FII2.24%0.04%
DII2.05%0.07%

Ownership Distribution

Retail & Public
23.04%
Promoters
72.67%
Foreign Institutions
2.24%
Domestic Institutions
2.05%

Category Trends

Foreign Institutions Breakdown
Total Holding: 2.24%
Net Change: +0.04%
Detailed Institutions1 institutions
Total Holding2.16%
Net Change+0.02%
Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
MALABAR INDIA FUND LIMITED
2.16%
0.02%
+0.02%
Jun 2026
Peers

Dr Agarwals Eye Hospital Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Dr Agarwals Eye Hospital Ltd is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
Abbott India Limited
₹56,049.28 Cr
Best Profit Growth
Bilcare Ltd
301.00 %
Highest Dividend Yield
Abbott India Limited
2.00 %

Peer Comparison

Company Name
09 · Chart Patterns

Dr Agarwals Eye Hospital Ltd chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for Dr Agarwals Eye Hospital Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

Dr Agarwals Eye Hospital Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Dr Agarwals Eye Hospital Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Dr Agarwals Eye Hospital Ltd stood at 56.4% of traded volume, against a 20-day average of 65.4%.

Avg Delivery (20D)65.4%-9.0 ppt latest vs avg
Highest Delivery82.3%on 20 Aug
Avg Volume (20D)1.5 K20-day run-rate
Conviction Trend↓ Weakening-9.0 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

Dr Agarwals Eye Hospital announcements: results, concalls, ratings, M&A.

Filings Dr Agarwals Eye Hospital sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Dr Agarwals Eye Hospital files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 40 documents below.

  1. 07 Jul 2026Company UpdateView PDF

    Company Update

    Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018, is submitted

  2. 02 Jul 2026AGM/EGMView PDF

    AGM/EGM

    Summary of proceedings of the NCLT convened meetings of the Equity Shareholders of Dr. Agarwal''s Eye Hospital Limited held on July 02, 2026 is…

  3. 01 Jun 2026Company UpdateView PDF

    Company Update

    Notice convening the meeting of the unsecured creditors of the Company pursuant to the order of the Hon''ble Tribunal, Chennai Bench, is submitted.

  4. 01 Jun 2026Company UpdateView PDF

    Company Update

    Notice convening the meeting of the Secured Creditors of the Company pursuant to the order of the Hon''ble NCLT, Chennai Bench.

  5. 01 Jun 2026AGM/EGMView PDF

    AGM/EGM

    Notice convening the Meeting of the Equity Shareholders of the Company pursuant to the Order of Honb''le NCLT, Chennai Bench, is submitted.

§ 10b · Reports & Decks

Investor decks & rating reports.

Corporate Actions

Dr Agarwals Eye Hospital dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Dr Agarwals Eye Hospital has declared, sequenced by announce and record date.

Dr Agarwals Eye Hospital corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Dr Agarwals Eye Hospital Ltd: business, sector, key facts.

What Dr Agarwals Eye Hospital Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Dr Agarwals Eye Hospital Ltd is a listed Indian equity, listed as NSE: DRAGARWQ, BSE: 526783.

DRAGARWQ
Listed Equity

Dr Agarwals Eye Hospital Ltd

NSE · DRAGARWQ·BSE · 526783·www.dragarwal.com
company facts
Employees
Sector
Headquarters
Market Cap₹2,588.41 Cr.
Listed OnNSE · BSE
leadership10 on record
Dr. Adil Agarwal M.B.B.S, M.S, MBA
CEO & Whole -Time Director
Dr. Amar Agarwal F.R.C.Ophth, F.R.C.S, M.S., MBBS
Founder, Chairman & MD
Dr. Athiya Agarwal D.O., F.R.S.H(Lon)
Founder & Whole Time Director
Mr. Aman Joshi
Head of Digital Marketing
Mr. Nandha Kumar
Senior Vice President of Operations of South & East India
Mr. N. R. Ugandhar
Senior Vice President of International Operations of BD and M&A
Mr. Yashwanth Venkat
Interim Chief Financial Officer
Ms. Meenakshi Jayaraman
Company Secretary & Compliance Officer
Ms. Suhasini K
Head of Human Resource
Terence Leo Seqi
General Manager of Projects
§ ∞ · Plainly Answered

Questions investors ask about Dr Agarwals Eye Hospital Ltd (DRAGARWQ).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Dr Agarwals Eye Hospital Ltd (DRAGARWQ)?

The current share price of Dr Agarwals Eye Hospital Ltd (DRAGARWQ) is ₹5,328.50. Today, the stock has declined by ₹45.00 (0.84%), trading in a range of ₹5,205.00 to ₹5,386.50. The stock opened at ₹5,363.50 with a trading volume of 649 shares.

02Is Dr Agarwals Eye Hospital Ltd stock a good investment for long-term?

Dr Agarwals Eye Hospital Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,588.41 Cr., P/E ratio of 33.71, ROE of 25.2%, and ROCE of 17.4%. The dividend yield stands at 0.13%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Dr Agarwals Eye Hospital Ltd stock?

The 52-week high price of Dr Agarwals Eye Hospital Ltd (DRAGARWQ) is ₹6,059.70, while the 52-week low is ₹4,600.00. Currently trading at ₹5,328.50, the stock is 15.84% above its 52-week low and 12.07% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Dr Agarwals Eye Hospital Ltd stock at the current price?

Whether to buy Dr Agarwals Eye Hospital Ltd stock at ₹5,328.50 depends on multiple factors. The stock is currently trading with a P/E ratio of 33.71 and P/B ratio of 7.42. Today's performance shows a loss of 0.84%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Dr Agarwals Eye Hospital Ltd and when is the next dividend?

Dr Agarwals Eye Hospital Ltd offers a dividend yield of 0.13%, which means for every ₹100 invested at the current price of ₹5,328.50, you can expect to receive approximately ₹0.13 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Dr Agarwals Eye Hospital Ltd?

Dr Agarwals Eye Hospital Ltd's key financial metrics include: P/E Ratio: 33.71, P/B Ratio: 7.42, ROE: 25.2%, ROCE: 17.4%, Dividend Yield: 0.13%, EPS: ₹145.00, Book Value: ₹717.00, and Debt-to-Equity: 0.94. The company's market cap stands at ₹2,588.41 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Dr Agarwals Eye Hospital Ltd stock performing today in the market?

Dr Agarwals Eye Hospital Ltd stock opened at ₹5,363.50 and is currently trading at ₹5,328.50, showing a decline of ₹45.00 (0.84%). The intraday high is ₹5,386.50 and low is ₹5,205.00. The trading volume stands at 649 shares, indicating moderate market participation today.

08What is the P/E ratio of Dr Agarwals Eye Hospital Ltd and what does it indicate?

Dr Agarwals Eye Hospital Ltd has a Price-to-Earnings (P/E) ratio of 33.71, which means investors are willing to pay 33.71 for every ₹1 of earnings. With an EPS of ₹145.00, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Dr Agarwals Eye Hospital Ltd (DRAGARWQ) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.